Evidence map›Paper›PMID 37433646›Full record

ArticleRespirology (Carlton, Vic.)2023

Long-term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia.

Qiang Zheng, Ingrid A Cox, Lucy Leigh, Barbara de Graaff, Fay H Johnston, Tamera J Corte, Luke D Knibbs, Petr Otahal, Vidya Navaratnam, Julie A Campbell and 7 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Respirology (Carlton, Vic.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Air pollution and alveolar health.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 2 countries.

Qiang ZhengMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.ORCID 0000-0002-7020-3239
Ingrid A CoxMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.ORCID 0000-0001-5130-4088
Lucy LeighHunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Barbara de GraaffMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Fay H JohnstonMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Tamera J CorteNHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, New South Wales, Australia.ORCID 0000-0002-5076-8929
Luke D KnibbsSchool of Public Health, The University of Sydney, Camperdown, New South Wales, Australia.
Petr OtahalMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Vidya NavaratnamDepartment of Respiratory Medicine, Sir Charles Gardiner Hospital, Perth, Western Australia, Australia.ORCID 0000-0002-2914-8012
Julie A CampbellMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Ian GlaspoleDepartment of Allergy and Respiratory Medicine, The Alfred Hospital, Melbourne, Western Australia, Australia.
Yuben MoodleyFaculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia.ORCID 0000-0002-0777-1196
Peter HopkinsNHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, New South Wales, Australia.
John A MackintoshThe Prince Charles Hospital, Metro North Hospital and Health Service, Chermside, Queensland, Australia.
Hasnat AhmadMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
E Haydn WaltersMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Andrew J PalmerMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
University of Tasmania · AUThe University of Sydney · AUCurtin University · AUHunter Medical Research Institute · AUPrince Charles Hospital · AUThe Alfred Hospital · AUThe University of Queensland · AUThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveLittle is known about the association between ambient air pollution and idiopathic pulmonary fibrosis (IPF) in areas with lower levels of exposure. We aimed to investigate the impact of air pollution on lung function and rapid progression of IPF in Australia.

methodsParticipants were recruited from the Australian IPF Registry (n = 570). The impact of air pollution on changes in lung function was assessed using linear mixed models and Cox regression was used to investigate the association with rapid progression.

resultsMedian (25th-75th percentiles) annual fine particulate matter (<2.5 μm, PM

conclusionLiving near a major road and increased PM

Indexed as

Air PollutantsAir PollutionIdiopathic Pulmonary FibrosisAustraliaEnvironmental ExposureHumansLungNitrogen DioxideParticulate MatterAir PollutantsNitrogen DioxideParticulate Matterair pollutionclinical epidemiologyenvironmental health issueinterstitial lung diseasepulmonary fibrosisrespiratory function tests

Identifiers

PMID37433646
PMCPMC10946479
OpenAlexW4383873720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.